Y-Intercept »

Zenas Biopharma shares owned by Y-Intercept

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Y-Intercept

Quarter filed Position value Share count Share price at filing
2026-06-30 $440k 17k 25.38

More positions owned by Y-Intercept

Amazon (AMZN)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Microsoft Corporation (MSFT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
salesforce (CRM)
Cme (CME)
Cognizant Technology Solutio Cl A (CTSH)
Intuit (INTU)
Qualcomm (QCOM)
CBOE Holdings (CBOE)
NVIDIA Corporation (NVDA)
Accenture Plc Ireland Shs Class A (ACN)
Monolithic Power Systems (MPWR)
JPMorgan Chase & Co. (JPM)

View all positions for Y-Intercept

Top funds holding Zenas Biopharma

FMR
Sr One Capital Management
NEA Management Company
Enavate Sciences GP
Federated Investors
BlackRock
Capital Research and Management Company - Division 3
Polar Capital Holdings
Royalty Pharma Sub-Manager
Fairmount Funds Management
NVP Associates
Wellington Management Company
State Street Corporation
Vanguard Capital Management
Bank of America Corporation

View all funds holding Zenas Biopharma